However, the IA individuals had lower MCP-1 levels than controls and T1D patientsThese data raise the possiblity that basal serum levels of MCP-1 may not be reflective of pathology in target tissues or an in vitro stimulus is needed to define differences based upon stage of the disease process[21]. The gene discussed is CCL2; the disease is type 1 diabetes mellitus.